CP-2550

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCP-2550
Drug Alias NameCP-2550
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBradykinin receptors antagonists
TargetsBradykinin receptors
Therapy Area/IndicationsInflammationAsthmaArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCortech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCortech
Active IndicationsN/A
Inactive IndicationsInflammationAsthmaArthritis

Other Information

ATC CodeN/A
Related LinksN/A